Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.
Apellis Pharmaceuticals in Los Angeles, CA is seeking a Senior Hematology Account Manager to drive sales and deepen relationships with key accounts in the hematology/oncology and rare disease space. You will serve as the primary commercial interface, develop business plans, and collaborate with patient services, reimbursement support, medical affairs, and operations to achieve territory objectives.
With 4+ years in biotech/pharma sales and account management, you will travel up to 75%
Opportunity awaits those up to the challenge of developing transformative therapies across a broad range of debilitating diseases.
The ideal candidate will be based in Los Angeles, CA.
Travel Requirements: Up to 75% travel, including overnights, depending on territory.
Bachelor's Degree
Base salary for this role will consider multiple factors, including but not limited to, candidate qualifications, relevant expertise, specialized skills, and industry experience in complement-targeted therapies. The targeted base salary range for this position is $138,000-$200,000. This range represents the base salary only and reflects Apellis' commitment to competitive compensation within the biopharmaceutical industry. The final salary offered may vary based on individual qualifications, business needs, and current market conditions.
Field
Apellis offers a comprehensive benefits package, including a 401(k) plan with company match, inclusive family building benefits, flexible time off, summer and winter shutdowns, paid family leave, disability and life insurance, and more! Visit https://apellis.com/careers/benefits/ to learn more.
Please note that as of May 14th, Biogen Inc. has acquired Apellis Pharmaceuticals. Click here to learn more about Benefits & Perks of working at Biogen: Benefits | Biogen
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company leading the way in complement science to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two C3-targeting medicines approved to treat four serious diseases. Breakthroughs for patients include the first-ever therapy for geographic atrophy, a leading cause of blindness, and the first treatment for patients 12 and older with C3G or primary IC-MPGN, two severe, rare kidney diseases. We believe we have only begun to unlock the potential of targeting C3 across many serious diseases.
Apellis is an equal opportunity employer and complies with all applicable federal, state and local fair employment practices laws. Apellis strictly prohibits and does not tolerate discrimination against employees, applicants or any other covered persons because of race, color, religion, creed, national origin or ancestry, ethnicity, sex (including pregnancy), gender (including gender nonconformity and status as a transgender or transsexual individual), age, physical or mental disability, citizenship, past, current or prospective service in the uniformed services, genetic information, marital status, AIDS/HIV status, smoker/nonsmoker, and occupational pneumoconiosis or any other characteristic protected under applicable federal, state or local law.
For San Francisco postings: Pursuant to the San Francisco Fair Chance Ordinance, we will consider for employment qualified applicants with arrest and conviction records.
Please note this job description is not designed to cover or contain a comprehensive listing of activities, duties or responsibilities that are required of the employee for this job. Duties, responsibilities and activities may change at any time with or without notice.